Response predictors to treatment with pegylated interferon in chronic hepatitis B
Braz. j. infect. dis
; 14(5): 519-525, Sept.-Oct. 2010. tab
Article
en En
| LILACS
| ID: lil-570570
Biblioteca responsable:
BR1.1
ABSTRACT
The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease have been studied, both before and during the course of medication. Therapy stopping rules have been proposed, which may be useful in patients presenting poor treatment tolerance. This review discusses the treatment response predictors usefulness, with emphasis on ALT, quantitative HBsAg and HBeAg, quantitative HBV-DNA and HBV genotype.
Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Antivirales
/
Polietilenglicoles
/
Virus de la Hepatitis B
/
Interferón-alfa
/
Hepatitis B Crónica
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Braz. j. infect. dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2010
Tipo del documento:
Article